Welcome to our dedicated page for BWX Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BWX Technologies, Inc. filings document the regulatory record of a NYSE-listed nuclear manufacturing and engineering company serving government and commercial markets. Its disclosures cover operating and financial results, segment performance, backlog-related business activity, risk factors, and material events connected to nuclear propulsion, nuclear fuel, and commercial nuclear operations.
BWXT’s SEC filings also address governance and capital structure. Recent records include proxy materials and annual meeting voting results, board and executive officer matters, registered common stock information, material agreements, and convertible senior notes due 2030 with related subsidiary guarantees.
BWX Technologies, Inc. director James M. Jaska reported a routine equity compensation-related transaction. On 12/10/2025, he acquired 21.82 dividend equivalent rights (DERs) tied to BWXT common stock at a price of $0 per right. Each DER represents a contingent right to receive one share of BWXT common stock.
The filing states these DERs accrued on seven restricted stock unit (RSU) grants for which Jaska has elected to defer receipt of the underlying shares. The DERs will be delivered proportionately with the related RSUs. Following this transaction, he beneficially owned 1,065.53 DERs, held directly.
BWX Technologies, Inc. director reports additional stock-linked rights. On 12/10/2025, a reporting person who serves as a director of BWX Technologies, Inc. (ticker BWXT) acquired 17.69 dividend equivalent rights tied to existing restricted stock unit (RSU) awards. Each RSU and each dividend equivalent right represents a contingent right to receive one share of BWXT common stock, with no cash exercise price.
The director has elected to defer receipt of the shares underlying these RSUs, and the related dividend equivalent rights will be delivered proportionately as the deferred RSUs are settled. Following this transaction, the director beneficially owned 741.34 dividend equivalent rights on a direct basis.
BWX Technologies, Inc. director Jan A. Bertsch reported receiving additional dividend equivalent rights tied to previously granted restricted stock units as of 12/10/2025. The filing shows 32.84 dividend equivalent rights credited at a price of $0, increasing her total derivative securities beneficially owned to 2,175.51, held directly. Each restricted stock unit and dividend equivalent right represents a contingent right to receive one share of BWXT common stock, and, under her deferral election, the dividend equivalent rights will be delivered proportionately with the related restricted stock units.
BWX Technologies reported new equity awards to a senior executive. On December 1, 2025, the company granted its SVP and General Counsel restricted stock units and stock options. The awards include 801 RSUs that vest in three equal annual installments beginning December 1, 2026, and an additional 1,714 RSUs that vest in two equal annual installments beginning the same date. The filing also shows an employee stock option grant for 2,337 shares of common stock with an exercise price of $174.93 per share, vesting in three equal annual installments from December 1, 2026 and expiring on December 1, 2035. These grants are reported as directly owned by the executive.
BWX Technologies (BWXT) filed a Form 3, the initial statement of beneficial ownership for its SVP and General Counsel. The reporting person disclosed no securities beneficially owned (0) and indicated the filing was made by one reporting person. The event date is 11/04/2025. The submission includes an Exhibit 24 power of attorney and was signed by an attorney-in-fact.
BWX Technologies (BWXT) reported insider transactions by President and CEO Rex D. Geveden. On 11/12/2025, he sold a total of 10,000 shares of common stock in multiple open-market trades pursuant to a Rule 10b5-1 trading plan adopted on 8/11/2025.
The reported weighted average prices for each tranche were $195.0825, $196.7407, $197.6916, $198.6728, and $199.3662. Footnotes state sales occurred within price ranges of $194.7200–$195.6100, $196.0200–$197.0100, $197.1350–$198.1300, $198.1700–$199.1250, and $199.1900–$199.8500, respectively. Following these transactions, he beneficially owned 187,594 shares directly.
BWX Technologies (BWXT) reported an initial statement of beneficial ownership on Form 3 for its VP & Chief Accounting Officer. The filing lists 23 shares of common stock held directly and 139 shares held indirectly through a 401(k) plan, based on the fair market value as of September 30, 2025. It also shows restricted stock units (RSUs) for 318, 450, and 259 shares at a $0 exercise price, with vesting beginning on February 29, 2025, February 26, 2026, and February 27, 2024, respectively. The event date is November 6, 2025.
BWX Technologies (BWXT) filed a Form 144 notice for a potential sale of 10,000 common shares through Charles Schwab & Co., Inc. with an aggregate market value of $1,979,005. The filing lists the NYSE as the exchange and an approximate sale date of 11/12/2025.
The shares were acquired via equity compensation, including 5,534 from a restricted stock lapse on 02/18/2024, 1,954 from RSU/PSU on 02/25/2024, and 2,512 from a restricted stock lapse on 02/27/2024. Shares outstanding were 91,426,744 at the time stated.
BWX Technologies issued $1.25 billion aggregate principal amount of 0% Convertible Senior Notes due 2030, guaranteed by certain subsidiaries and sold to institutional buyers under Rule 144A. The notes initially convert at 3.8094 shares per $1,000 (conversion price about $262.51) and may be redeemed by the company on or after November 6, 2028 if price and tradability conditions are met, including the stock trading above 130% of the conversion price. Make‑whole and fundamental change provisions apply, with a maximum make‑whole conversion rate of 5.0474 shares per $1,000.
To mitigate potential dilution, BWXT entered into capped call transactions covering the shares underlying the notes with an initial cap price of $396.24 per share (100% above the $198.12 last sale on November 5, 2025). The company also put in place a $1.25 billion senior secured revolving credit facility maturing in 2030; as of November 10, 2025, there were no borrowings outstanding and $1.25 billion remained available, excluding $1.4 million in undrawn letters of credit.
BWX Technologies announced plans to commence, subject to market conditions and other factors, a private offering of $1.0 billion aggregate principal amount of convertible senior notes due 2030 to qualified institutional buyers under Rule 144A. The notes will be guaranteed by the Company’s present and future direct and indirect wholly owned domestic subsidiaries that guarantee its existing and future capital markets indebtedness.
Concurrently with the closing of the notes offering, BWXT expects to enter into a Second Amended and Restated Credit Agreement providing a five-year $1.25 billion senior secured revolving credit facility, with Wells Fargo Bank, National Association as administrative agent. The facility will be secured by first-priority liens on certain assets of the Company and guarantors, excluding subsidiaries comprising a portion of the Government Operations segment. Entry into the new credit facility is subject to prevailing market conditions, and the notes offering is not conditioned on the facility closing.